4//SEC Filing
Flynn James P 4
Accession 0001209191-24-002479
CIK 0000907654other
Filed
Jan 30, 7:00 PM ET
Accepted
Jan 31, 4:25 PM ET
Size
5.9 KB
Accession
0001209191-24-002479
Insider Transaction Report
Form 4
Flynn James P
Director
Transactions
- Award
Stock Option (right to buy)
2024-01-30+6,000→ 6,000 totalExercise: $1.64Exp: 2034-01-30→ Common Stock (6,000 underlying)
Footnotes (1)
- [F1]Grant to the Reporting Person of a stock option under the 2020 Equity Incentive Plan, vesting in 12 equal monthly installments beginning as of January 30, 2024, subject to the Reporting Person continuing to provide Continuous Service (as defined in the 2020 Equity Incentive Plan) through such date. If the Reporting Person's service as a director of the Issuer terminates in connection with or at any time following a change in control (for whatever reason), then any unexpired options that remain unvested shall become fully vested.
Documents
Issuer
ARCA biopharma, Inc.
CIK 0000907654
Entity typeother
Related Parties
1- filerCIK 0001955965
Filing Metadata
- Form type
- 4
- Filed
- Jan 30, 7:00 PM ET
- Accepted
- Jan 31, 4:25 PM ET
- Size
- 5.9 KB